Cargando…
Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice
BACKGROUND: Mesenchymal stem cells (MSCs) have emerged as a promising therapy for type 2 diabetes (T2D). Mechanistic researches demonstrate that the anti-diabetic effect of MSCs is partially mediated by eliciting macrophages into an anti-inflammatory phenotype thus alleviating insulin resistance. Ho...
Autores principales: | Gao, Jieqing, Cheng, Yu, Hao, Haojie, Yin, Yaqi, Xue, Jing, Zhang, Qi, Li, Lin, Liu, Jiejie, Xie, Zongyan, Yu, Songyan, Li, Bing, Han, Weidong, Mu, Yiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700792/ https://www.ncbi.nlm.nih.gov/pubmed/31426846 http://dx.doi.org/10.1186/s13287-019-1338-2 |
Ejemplares similares
-
Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting β Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice
por: Xue, Jing, et al.
Publicado: (2020) -
Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice
por: Yin, Yaqi, et al.
Publicado: (2018) -
Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy Ameliorates Nonalcoholic Fatty Liver Disease in Obese Type 2 Diabetic Mice
por: Li, Bing, et al.
Publicado: (2019) -
Human umbilical cord-derived mesenchymal stem cells alleviate insulin resistance in diet-induced obese mice via an interaction with splenocytes
por: Xue, Jing, et al.
Publicado: (2022) -
Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats
por: Sun, Xiaoya, et al.
Publicado: (2017)